[Skip to Navigation]
August 22, 2019

The Adolescent Vaping Epidemic in the United States—How It Happened and Where We Go From Here

Author Affiliations
  • 1Department of Otolaryngology–Head and Neck Surgery, University of North Carolina at Chapel Hill
  • 2Department of General Pediatrics and Adolescent Medicine, University of North Carolina at Chapel Hill
  • 3Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
  • 4Department of Pathology, University of North Carolina at Chapel Hill
  • 5Marsico Lung Institute, University of North Carolina at Chapel Hill
JAMA Otolaryngol Head Neck Surg. 2019;145(10):885-886. doi:10.1001/jamaoto.2019.2410

On December 18, 2018, the US Surgeon General declared e-cigarette vaping among adolescents an “epidemic.”1 This declaration coincided with a report in The New England Journal of Medicine2 highlighting a 10% increase in youth vaping between 2017 and 2018, the equivalent of an additional estimated 1.3 million teenagers. In a public hearing in January 2019, the former US Food and Drug Administration (FDA) Commissioner, Scott Gottlieb, stated that e-cigarettes pose an “existential threat” to youth, and called for exploration of drug therapies to help adolescents overcome addiction.3 In February 2019, the Morbidity and Mortality Weekly Report4 from the Centers for Disease Control and Prevention (CDC) declared that the e-cigarette surge has erased recent progress in preventing tobacco use among youth. These statements summarize the current story of how loosely regulated products intended to help individuals quit traditional combustible cigarettes became the fastest growing abused substance and the Achilles’ heel of our youngest generation.

Add or change institution